Skip to main content
Skip to footer
Home
About
Franchise
Studies
Contact
Home
About
Franchise
Studies
Contact
Register
PDF:
True
Asthma
12 August 2024
Researching new approaches to control asthma symptoms and improve quality of life for patients with this respiratory condition.
Arnasa COPD
12 August 2024
Evaluating novel treatments for chronic obstructive pulmonary disease to enhance breathing and overall lung function.
Osteoporosis Alvobond
12 August 2024
Investigating new approaches to prevent and treat osteoporosis, a condition that weakens bones and increases fracture risk.
Librexia ACS
12 August 2024
Evaluating a potential new treatment for acute coronary syndrome, a term for conditions where blood flow to the heart is…
HERMES Heart Failure
12 August 2024
Exploring innovative therapies for heart failure to improve patient outcomes and quality of life.
Cultivate Crohn’s Disease
12 August 2024
Investigating novel approaches to manage Crohn's disease, a chronic inflammatory bowel condition.
Elevate Ulcerative Colititis
12 August 2024
Assessing innovative therapies for ulcerative colitis to improve patient care and disease management.
Debio Osteomyelitis
12 August 2024
Researching new treatments for osteomyelitis, a serious bone infection that can be challenging to treat.
WET AMD Alvoeye
12 August 2024
Testing innovative treatments for wet age-related macular degeneration, a leading cause of vision loss in older adults.
Autism
12 August 2024
Exploring new interventions and support strategies for individuals with autism spectrum disorder.